1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 13 APRIL 2015

Key Pharma News 13 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Opportunities For Vaccine Manufacturers Still Exist Despite Waning Ebola Crisis
Industry Brief - Merck KGaA/Pfizer Finalise Deal To Co-Promote Xalkori
Industry Trend Analysis - Aduro's IPO To Benefit From Novartis Deal
Industry Trend Analysis - Infinity/AbbVie's Actions Indicate Confidence In Duvelisib's Future Success
Industry Brief - Merck Serono/Intrexon Enter Collaboration For CAR-T Cancer Therapies
Industry Trend Analysis - CAR-T Space Sees High Investment Despite High-Risk Environment
Industry Brief - Pfizer To Cease Vaccines Sales Business In China
Industry Brief - BMS Completes Flexus Biosciences Acquisition
Industry Brief - Teva To Acquire Auspex Pharmaceuticals
Industry Brief - Janssen Completes Divestiture Of US Licence Rights To Nucynta Franchise
Industry Brief - Horizon To Acquire Hyperion Therapeutics
Industry Brief - Genentech To Expand Hillsboro Facility
Industry Trend Analysis - Actavis Acquisition Will Establish A New Regional Presence For Amneal
Industry Brief - Daiichi Sankyo, Inc/Asubio Pharmaceuticals To Merge
Industry Brief - UCB To Sell Established Brands Portfolio In India To Dr Reddy's; Focus On Core Business
Industry Trend Analysis - Gilead To Maintain Dominance In HIV Market
Industry Brief - FDA Accepts Tresiba/Ryzodeg Resubmissions For Review
Industry Brief - BI Seeks FDA Approval For Additional Pradaxa Indication
Industry Brief - Genzyme's Cerdelga Approved In Japan For Type I GD
Industry Trend Analysis - Viable Generic Sofosbuvir Market Will Increase Pricing Pressures For Gilead
Industry Trend Analysis - Mysimba Will Have Fewer Competitors But Sales Dampened By Safety Concerns
Industry Brief - CHMP Recommends Empagliflozin/Metformin HCl For Approval
Industry Brief - Eisai's Lenvima Gains CHMP Positive Opinion For RAI-R DTC
Industry Brief - Helsinn Receives Positive CHMP Opinion On Akynzeo For CINV Prevention
Industry Brief - Otsuka Granted Approval In Japan For New Formulation Of Abilify
Industry Brief - Velcade Approved In UK For First-Line MCL
Industry Brief - EMA Validates Zinbryta MAA For MS
Industry Trend Analysis - Kyprolis Unlikely To Rival Pomalyst Despite Priority Review
Industry Brief - FDA Approves Zytiga Label Update
Industry Brief - Hospira's Infliximab Launched In Canada
Industry Brief - Humira Gains EU Approval For Plaque Psoriasis In Children
Industry Brief - Iclusig Approved In Canada For T315I Mutation-Positive CML/Ph+ ALL
Industry Brief - Companies Gain US Amlodipine+Valsartan Approvals
Industry Brief - EC Approves Expanded Vectibix Use
Industry Brief - Pfizer/Lilly Preparing To Resume Phase III Chronic Pain Programme For Tanezumab
Industry Brief - GSK To Establish Global Vaccines R&D Centre In US
Industry Brief - Shire/FDA Reach Agreement On Regulatory Path For SHP465
Industry Trend Analysis - Personalised Medicine Leading To Fewer Drugs Being Shelved
Industry Trend Analysis - Diagnostics Are Key To Combatting Antibiotic Resistance

Table Of Contents

Key Pharma News 13 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.